medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2005, Número 2

<< Anterior Siguiente >>

Ann Hepatol 2005; 4 (2)


Prediction of the hepatitis C viremia using immunoassay data and clinical expertise

Chiquete E, Sánchez LV, Maldonado M, Quezada D, Panduro A

Idioma: Ingles.
Referencias bibliográficas: 29
Paginas: 107-114
Archivo PDF: 82.54 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Memom MI, Memom MA. Hepatitis C: an epidemiological review. J Viral Hepat 2002; 9: 84-100.

  2. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L, et al. Routs of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 1691-1696.

  3. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003; 362: 2095-3000.

  4. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB (eds). Diagnosis and screening. In: Evidence-based medicine: How to teach and practice EBM. 2nd ed. Edinburgh: Churchill-Livingstone; 2000: 67-93.

  5. Alter MJ, Kuhnert WL, Finelli L; Centers for Disease Control and Prevention. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003 Feb 7; 52 (RR-3): 1-13.

  6. Dal Molin G, Tiribelli C, Campello C. A rational use of laboratory tests in the diagnosis and management of hepatitis C virus infection. Ann Hepatol 2003; 2: 76-83.

  7. McFarlane IG, Smith HM, Johnson PJ, Bray GP, Vergani D, Williams R. Hepatitis C virus antibodies in chronic active hepatitis: Pathogenetic factor or false-positive result? Lancet 1990; 335: 754-757.

  8. Aceti A, Taliani G, Bac C, Sebastiani A. Anti-HCV false positivity in malaria. Lancet 1990; 336: 1442-1443.

  9. Schirm J, van Loon AM, Valentine-Thon E, Klapper PE, Reid J, Cleator GM. External quality assessment program for qualitative and quantitative detection of hepatitis C virus RNA in diagnostic virology. J Clin Microbiol 2002; 40: 2973-2980.

  10. Sánchez LV, Maldonado M, Bastidas-Ramírez BE, Norder H, Panduro A. Genotypes and S-gene variability of Mexican hepatitis B virus strains. J Med Virol 2002; 68: 22-34.

  11. Kiely P, Kay D, Parker S, Piscitelli L. The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays. Transfusion 2004; 44: 349-358.

  12. Rivas-Estilla AM, Sánchez LV, Matsui O, Campollo O, Armendáriz-Borunda Juan, Segura-Ortega JE, Panduro A, et al. Identification of hepatitis C virus (HCV) genotypes in infected patients from the west of Mexico. Hepatology Research 1998; 12: 121-130.

  13. Navas S, Castillo I, Carreńo V. Detection of plus and minus HCV RNA in normal liver of anti-HCV-positive patients. Lancet 1993; 341: 904-905.

  14. Haydon GH, Jarvis LM, Blair CS, Simmonds P, Harrison DJ, Simpson KJ, Hayes PC. Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut 1998; 42: 570-575.

  15. Dries V, von Roth I, Müller M, Gerken G, Schirmacher P, Odenthal M, Bartenschlager R, et al. Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. Hepatology 1999; 29: 223-229.

  16. Castillo I, Pardo M, Bartolomé J, Ortiz-Movilla N, Rodriguez-Inigo E, de Lucas S, Salas C, et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 2004; 189: 7-14.

  17. Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998; 280: 1690-1691.

  18. Sookoian S, Castańo G. Evaluation of a third generation anti-HCV assay in predicting viremia in patients with positive HCV antibodies. Ann Hepatol 2002; 4: 179-178.

  19. Dufour DR, Talastas M, Fernandez MDA, Harris B. Chemiluminescence assay improves specificity of hepatitis C antibody detection. Clin Chem 2003; 49: 940-944.

  20. Bossi V, Galli C. Quantitative signal of anti-HCV by an automated assay predicts viremia in a population at high prevalence of hepatitis C virus infection. J Clin Virol 2004; 30: 45-49.

  21. Polywka S, Schröter M, Feucht HH, Zöllner B, Laufs R. Relevance in reactivity in commercially available hepatitis C virus antibody assay. J Clin Microbiol 2001; 39: 1665-1668.

  22. Lu SN, Tung HD, Chen TM, Lee CM, Wang JH, Hung CH, Chen CH, et al. Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion? J Viral Hepat 2004; 11: 563-570.

  23. Marín-López A. Bancos de Sangre. Rev Gastroenterol Mex 2002; 67: S11-S12.

  24. Méndez-Sánchez N, Aguilar-Ramírez JR, Reyes A, et al. Etiology of liver cirrhosis in Mexico. Ann Hepatol 2004; 3: 30-33.

  25. CONADICT. Statistics on drug abuse patterns, Mexico. 2001. Available at http://www.conadic.gob.mx/ Accessed August 24, 2004.

  26. Vivas-Arceo C, Benavides SA, De Jesus Trujillo J, Panduro A, Rivas-Estilla AM. Hepatitis C virus: prevalence and routes of infection among blood donors of West Mexico. Hepatol Res 2003; 25: 115-123.

  27. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, et al. The natural history of hepatitis C virus infection. Host, viral, and environmental factors. JAMA 2000; 284: 450-456.

  28. Jara P, Resti M, Hierro L, Giacchino R, Barbera C, Zancan L, Crivellaro C, et al. Chronic hepatitis C virus infection in childhood: Clinical Patterns and evolution in 224 white children. Clin Infect Dis 2003; 36: 275-280.

  29. Casiraghi MA, De Paschale M, Romano L, Biffi R, Assi A, Binelli G, Zanetti AR. Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth. Hepatology 2004; 39: 90-96.




2020     |     www.medigraphic.com